These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 8817406)
1. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure. Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile. Prager G; Klein P; Schmitt M; Prager R J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076 [TBL] [Abstract][Full Text] [Related]
3. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril. Waeber B; Weidmann P; Wohler D; Le Bloch Y Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894 [TBL] [Abstract][Full Text] [Related]
4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
5. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy. Ibrahim MM; el-Boghdadly B; Zaghloul SS J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring. Martina B; Weinbacher M; Gasser P; Rhyner K; Köhler M; Wohler D; LeBloch Y; Bart T J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S89-92. PubMed ID: 7700075 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring. Podjarny E; Korzets Z; Bernheim J J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure. Nakanishi T; Takahashi H; Nishimura M; Yoshimura M Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients. de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517 [TBL] [Abstract][Full Text] [Related]
11. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME; Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy. Imanishi M; Yoshioka K; Okumura M; Konishi Y; Tanaka S; Fujii S; Kimura G Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance. Nilsson PM; Hedblad B; Donaldson J; Berglund G Blood Press; 2007; 16(2):95-100. PubMed ID: 17612907 [TBL] [Abstract][Full Text] [Related]
15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
16. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy. Lacourcière Y; Leenen F; Rangno R; Spence JD; Lenis JH; Myers MG Can J Cardiol; 1994; 10(6):605-10. PubMed ID: 8044721 [TBL] [Abstract][Full Text] [Related]
18. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
19. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920 [TBL] [Abstract][Full Text] [Related]
20. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension]. Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]